Astera Labs CEO’s trust sells 2,967 shares
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra, through a living trust, reported open-market sales of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra, through a living trust, reported open-market sales of Common Stock. On April 15, 2026, the living trust sold 2,767 shares at $174.5682 per share and 200 shares at $175.03 per share.
The filing states these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025, indicating they were scheduled in advance. Following the trades, the living trust holds 4,405,015 shares, and the filing also lists additional indirect holdings in multiple estate-planning trusts and a direct holding of 1,452,739 shares of Common Stock.
Insider Trade Summary 10b5-1
Net Seller: 2,967 shares
Net Sell
8 txns
Insider
Mohan Jitendra
Role
Chief Executive Officer
Sold
2,967 shs ($518K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,767 | $174.5682 | $483K |
| Sale | Common Stock | 200 | $175.03 | $35K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 4,405,015 shares (Indirect, By Living Trust);
Common Stock — 699,999 shares (Indirect, By Trust);
Common Stock — 700,000 shares (Indirect, By 2021 Trust 1);
Common Stock — 700,000 shares (Indirect, By 2021 Trust 2);
Common Stock — 450,001 shares (Indirect, By 2022 Trust 1);
Common Stock — 450,001 shares (Indirect, By 2022 Trust 2);
Common Stock — 1,452,739 shares (Direct)
Footnotes (8)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.0000 to $174.9100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F5. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F6. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F7. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F8. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold (first trade): 2,767 shares at $174.5682
Shares sold (second trade): 200 shares at $175.03
Total shares sold: 2,967 shares
+3 more
6 metrics
Shares sold (first trade)
2,767 shares at $174.5682
Open-market sale by living trust on April 15, 2026
Shares sold (second trade)
200 shares at $175.03
Open-market sale by living trust on April 15, 2026
Total shares sold
2,967 shares
Net shares sold in reported transactions, net-sell direction
Living trust holdings after sale
4,405,015 shares
Common Stock held indirectly by living trust following transactions
Direct holdings after transactions
1,452,739 shares
Common Stock held directly by reporting person as of April 15, 2026
Estate-planning trust holding
699,999 shares
Common Stock held indirectly by a trust labeled "By Trust"
Key Terms
Rule 10b5-1 trading plan, weighted average price, estate planning trust, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust (the "Trust")."
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent, if any, of his pecuniary interest therein..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Astera Labs (ALAB) disclose in this Form 4?
Astera Labs reported that a living trust associated with CEO Mohan Jitendra sold 2,967 Common Stock shares in open-market trades. The sales occurred on April 15, 2026, at prices around the mid-$170s per share, as detailed in the Form 4 filing.
Was the Astera Labs (ALAB) CEO’s trust sale made under a Rule 10b5-1 plan?
Yes. The filing states the reported sales occurred automatically under a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2025. Such plans pre-schedule trades, reducing the significance of short-term market timing perceptions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates